Advanced Therapeutics in Diabetes (ATD)

Advanced Therapeutics in Diabetes (ATD) refers to innovative treatments designed to better manage and potentially improve diabetes outcomes. This includes technologies like continuous glucose monitors (CGMs), insulin pumps, and smart insulin systems that deliver insulin more precisely. It also involves new medications, such as SGLT2 inhibitors and GLP-1 receptor agonists, which help control blood sugar more effectively. The goal of ATD is to customize care, reduce complications, and improve quality of life for people with diabetes by integrating cutting-edge science with personalized treatment strategies.